Abstract Background Activating mutations in the PIK3CA gene have been identified in a variety of human malignancies and are commonly detected in hotspot codons located in the helical and kinase domains in exons 9 and 20. Existing methodologies for the detection of PIK3CA mutations are time-consuming and/or expensive. In the present study we describe the first application of a PIK3CA SNaPshot assay to the screening of frequent mutations in these exons. Findings A SNaPshot assay for the simultaneous detection of four frequent PIK3CA hotspot mutations (E542K, E545G, E545K and H1047R) has been developed and evaluated. The assay combines multiplex PCR amplification with a multiplex primer extension assay to allow targeted detection of all four m...
The phosphatidylinositol 3-kinases (PIK3s) are lipid kinases. Mutation in the exon 9 and exon 20 det...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
<p>(a) The heterozygous p.E542K (c.G1624A) <i>PIK3CA</i> hotspot mutation was detected in sample no....
phoinositide-3-kinase, catalytic, alpha polypeptide) have recently been described in a number of can...
The phosphatidylinositol 3-kinases (PI3Ks) are a family of proteins involved in the regulation of ce...
PIK3CA is one of the two most frequently mutated genes in breast cancers, occurring in 30-40% of cas...
International audienceWith the approval of new therapies targeting the PI3K pathway, the detection o...
<p>For the digital PCR assay, signals from wild-type-specific probe are detected as blue, and signal...
Breast cancer is the leading cause of cancer-related deaths in women worldwide. Approximately 40% of...
A subgroup of non-small cell lung cancer (NSCLC) cases harbour mutations in classical oncogenes, whi...
PIK3CA is one of the two most frequently mutated genes in breast cancers, occurring in 30-40% of cas...
The data in this article are related to the research article entitled “Optimization of melting analy...
a<p>Frequency of the patient with mutated DNA.</p><p>Detection of <i>PIK3CA</i> mutation (E542K, E54...
Somatic mutations of phosphoinositide-3-kinase, catalytic, a; PIK3CA gene have been reported in\ud s...
The phosphatidylinositol 3-kinases (PIK3s) are lipid kinases. Mutation in the exon 9 and exon 20 det...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
<p>(a) The heterozygous p.E542K (c.G1624A) <i>PIK3CA</i> hotspot mutation was detected in sample no....
phoinositide-3-kinase, catalytic, alpha polypeptide) have recently been described in a number of can...
The phosphatidylinositol 3-kinases (PI3Ks) are a family of proteins involved in the regulation of ce...
PIK3CA is one of the two most frequently mutated genes in breast cancers, occurring in 30-40% of cas...
International audienceWith the approval of new therapies targeting the PI3K pathway, the detection o...
<p>For the digital PCR assay, signals from wild-type-specific probe are detected as blue, and signal...
Breast cancer is the leading cause of cancer-related deaths in women worldwide. Approximately 40% of...
A subgroup of non-small cell lung cancer (NSCLC) cases harbour mutations in classical oncogenes, whi...
PIK3CA is one of the two most frequently mutated genes in breast cancers, occurring in 30-40% of cas...
The data in this article are related to the research article entitled “Optimization of melting analy...
a<p>Frequency of the patient with mutated DNA.</p><p>Detection of <i>PIK3CA</i> mutation (E542K, E54...
Somatic mutations of phosphoinositide-3-kinase, catalytic, a; PIK3CA gene have been reported in\ud s...
The phosphatidylinositol 3-kinases (PIK3s) are lipid kinases. Mutation in the exon 9 and exon 20 det...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...